Insys Liquidation Trust v. McKesson Corporation

CourtUnited States Bankruptcy Court, D. Delaware
DecidedJuly 21, 2021
Docket21-50176
StatusUnknown

This text of Insys Liquidation Trust v. McKesson Corporation (Insys Liquidation Trust v. McKesson Corporation) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Insys Liquidation Trust v. McKesson Corporation, (Del. 2021).

Opinion

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE

In re: ) Chapter 11 ) INSYS THERAPEUTICS, INC., et al., ) Case No. 19-11292(JTD) ) (Jointly Administered) Liquidating Debtors. ) __________________________________________) INSYS LIQUIDATION TRUST, by and through ) WILLIAM HENRICH, as LIQUIDATING ) TRUSTEE, ) Adv. No. 21-50176(JTD) ) Plaintiff, ) ) v. ) ) MCKESSON CORPORATION, RXC ) ACQUISITION COMPANY (SUCCESSOR BY ) MERGER TO MCKESSON SPECIALTY ) ARIZONA, INC.) AND NDC HEALTH ) CORPORATION (D/B/A RELAY HEALTH). ) ) Defendants. ) Re: D.I. 14

OPINION AND ORDER

Plaintiff Insys Liquidation Trust, by and through William Henrich as Liquidating Trustee (the “Trustee”) commenced this action to avoid and recover allegedly preferential and fraudulent transfers.1 Defendants McKesson Corporation d/b/a RXCrossRoads by McKesson (“McKesson”), RelayHealth Pharmacy Solutions (“RelayHealth”), and McKesson Specialty Arizona, Inc. (“MSAZ”) (collectively “Defendants”) moved to dismiss pursuant to Federal Rules of Civil Procedure 8, 9, and 12(b)(6), made applicable by Federal Rules of Bankruptcy Procedure 7008, 7009, and 7012.2 For the reasons set forth below, the Motion is denied in part and granted in part.

1 Adv. D.I. 1 (the “Complaint”). 2 Adv. D.I. 14 (the “Motion” and the “Opening Brief”) BACKGROUND Debtors were a specialty pharmaceutical company that developed and commercialized certain drugs and novel drug delivery systems for targeted therapies. Defendants were parties to multiple prepetition agreements with Debtors pursuant to which they assisted with the

development, operationalization, implementation, and maintenance of certain programs related to the drugs that Debtors sold. Defendants and Debtors were also parties to a distribution agreement, pursuant to which Defendant McKesson purchased pharmaceutical products from Debtors.3 Debtors commenced their bankruptcy cases on June 10, 2019. As part of their first day motions, Debtors filed a Motion Pursuant to 11 U.S.C. §§ 105(a) and 363(b) for Authority to (I) Maintain and Administer Prepetition Customer Programs, Promotions, and Practices and (II) Pay and Honor Related Prepetition Obligations (the “Customer Motion”).4 The Customer Motion named Defendants as “critical customers” and requested authorization to pay all prepetition amounts owed to Defendants, among others, in order to continue to receive

necessary services provided by such customers. The motion was granted and a Final Order Pursuant to 11 U.S.C. §§ 105(a) and 363(b) for Authority to (I) Maintain and Administer Prepetition Customer Programs and (II) Pay and Honor Related Prepetition Obligations (the “Customer Order”) was entered.5 The Customer Order provides that “The Debtors are authorized, but not directed . . . to maintain and administer the Customer Programs,” which counsel for Defendants confirmed during the hearing included those involving Defendants.6

3 Opening Brief at 3-4. 4 D.I. 9. 5 D.I. 232. 6 D.I. 232, ¶¶ 2. On February 23, 2021, the Trustee filed the Complaint asserting six causes of action that seek to (i) avoid prepetition transfers to defendant RelayHealth totaling $15,524.17 and to defendant MSAZ totaling $139,296.90 (the “Transfers”) and recover the value of those transfers pursuant to 11 U.S.C. §§ 547, 548, 549, and/or 550; and (ii) object to the claims Defendants filed

in Debtors’ bankruptcy cases. Defendants moved to dismiss all counts. The Trustee consented to dismissal of the third count. I will therefore address the remaining five counts only. LEGAL STANDARD This Motion is brought under Rules 8(a), 9(b), and 12(b)(6). Rule 8(a) requires a complaint to contain “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. Proc. 8(a). This statement must provide defendant with “fair notice of what the plaintiff’s claim is and the grounds upon which it rests.” Conley v. Gibson, 355 U.S. 41, 45 (1957). Where a complaint alleges fraud, Rule 9(b) mandates that “a party must state with particularity the circumstances constituting fraud or mistake.” Fed. R. Civ. Proc. 9(b).

A Rule 12(b)(6) motion challenges the sufficiency of the factual allegations in the complaint. Kost v. Kozakiewicz, 1 F.3d 176, 183 (3d Cir. 1993). To survive a motion to dismiss, the complaint must contain sufficient factual matter, accepted as true, “to state a claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). A claim is facially plausible when “the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citing Twombly, 550 U.S. at 556). The court must draw all reasonable inferences in favor of the plaintiff. See, e.g., Alpizar-Fallas v. Favero, 908 F.3d 910, 914 (3d Cir. 2018). On a motion to dismiss, “[t]he defendant bears the burden to show that the plaintiff's claims are not plausible.” In re LSC Wind Down, LLC, 610 B.R. 779, 783 (Bankr. D. Del. 2020). In weighing a motion to dismiss, the court should undertake a three-part analysis. “First, the court must take note of the elements needed for a plaintiff to state a claim.” Santiago v.

Warminster Twp., 629 F.3d 121, 130 (3d Cir. 2010) (citing Iqbal, 556 U.S. at 675). Second, the court must separate the factual and legal elements of the claim, accepting all the complaint's well-pled facts as true and disregarding any legal conclusions. Id.; Fowler v. UPMC Shadyside, 578 F.3d 203, 210 (3d Cir. 2009) (citing Iqbal, 556 U.S. at 679). Third, the court must determine whether the facts alleged in the complaint are sufficient to show that the plaintiff has a plausible claim for relief. Santiago, 629 F.3d at 130. DISCUSSION I. Count I: 11 U.S.C. § 547 The first cause of action seeks to avoid the Transfers as preferential under Section 547 of the Bankruptcy Code, which provides that the Trustee may avoid:

Any transfer of an interest of the debtor in property –

(1) to or for the benefit of a creditor; (2) for or on account of an antecedent debt owed by the debtor before such transfer was made; (3) made while the debtor was insolvent; (4) made – (A) on or within 90 days before the date of the filing of the petition; (B) between ninety days and one year before the date of the filing of the petition, if such creditor at the time of such transfer was an insider; and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Santiago v. Warminster Township
629 F.3d 121 (Third Circuit, 2010)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Ana Alpizar-Fallas v. Frank Favero
908 F.3d 910 (Third Circuit, 2018)
Kost v. Kozakiewicz
1 F.3d 176 (Third Circuit, 1993)
In re ID Liquidation One, LLC
503 B.R. 392 (D. Delaware, 2013)
Oneida Motor Freight, Inc. v. United Jersey Bank
848 F.2d 414 (Third Circuit, 1988)

Cite This Page — Counsel Stack

Bluebook (online)
Insys Liquidation Trust v. McKesson Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/insys-liquidation-trust-v-mckesson-corporation-deb-2021.